Glucagonoma MRI: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) Created page with "{{Glucagonoma}} {{CMG}} ==Overview== ==References== {{reflist|2}} Category:Disease Category:Types of cancer Category:Oncology Category:Endocrinology {{Wiki..." |
Mahshid |
||
| (19 intermediate revisions by 8 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Glucagonoma}} | {{Glucagonoma}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{PSD}}, {{MAD}} | ||
==Overview== | ==Overview== | ||
Abdominal MRI is helpful in the diagnosis of glucagonoma. On abdominal MRI, glucagonoma is characterized by a mass which is hypo-intense on T1-weighted MRI and hyper-intense on T2-weighted MRI. MRI is preferred over contrast-enhanced CT or [[somatostatin receptor]] scintigraphy for assessing metastasis. | |||
==MRI== | |||
*Findings on abdominal MRI suggestive of glucagonoma include:<ref name="pmid25789004">{{cite journal| author=Lv WF, Han JK, Liu X, Wang SC, Pan BO, Xu AO| title=Imaging features of glucagonoma syndrome: A case report and review of the literature. | journal=Oncol Lett | year= 2015 | volume= 9 | issue= 4 | pages= 1579-1582 | pmid=25789004 | doi=10.3892/ol.2015.2930 | pmc=PMC4356379 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25789004 }} </ref> | |||
**T1: low signal intensity | |||
**T2: high signal intensity | |||
*MRI is preferred over contrast-enhanced CT or [[somatostatin receptor]] scintigraphy for assessing [[metastasis]]. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
[[Category: | {{WS}} | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 01:48, 27 November 2017
|
Glucagonoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Glucagonoma MRI On the Web |
|
American Roentgen Ray Society Images of Glucagonoma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2], Mohammed Abdelwahed M.D[3]
Overview
Abdominal MRI is helpful in the diagnosis of glucagonoma. On abdominal MRI, glucagonoma is characterized by a mass which is hypo-intense on T1-weighted MRI and hyper-intense on T2-weighted MRI. MRI is preferred over contrast-enhanced CT or somatostatin receptor scintigraphy for assessing metastasis.
MRI
- Findings on abdominal MRI suggestive of glucagonoma include:[1]
- T1: low signal intensity
- T2: high signal intensity
- MRI is preferred over contrast-enhanced CT or somatostatin receptor scintigraphy for assessing metastasis.
References
- ↑ Lv WF, Han JK, Liu X, Wang SC, Pan BO, Xu AO (2015). "Imaging features of glucagonoma syndrome: A case report and review of the literature". Oncol Lett. 9 (4): 1579–1582. doi:10.3892/ol.2015.2930. PMC 4356379. PMID 25789004.